The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity.

Nichols, Brooke E; Jamieson, Lise; Zhang, Sabrina R C; Rao, Gabriella A; Silal, Sheetal; Pulliam, Juliet R C; Sanne, Ian; Meyer-Rath, Gesine

Nichols, Brooke E; Jamieson, Lise; Zhang, Sabrina R C; Rao, Gabriella A; Silal, Sheetal; Pulliam, Juliet R C; Sanne, Ian; Meyer-Rath, Gesine.

Afiliación

Nichols BE; Department of Global Health, School of Public Health, Boston University, Boston, Massachusetts, USA.
Jamieson L; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Zhang SRC; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Rao GA; Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA.
Silal S; Department of Global Health, School of Public Health, Boston University, Boston, Massachusetts, USA.
Pulliam JRC; Modelling and Simulation Hub, Africa, Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.
Sanne I; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Meyer-Rath G; South African Department of Science and Innovation-National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.

Clin Infect Dis ; 72(9): 1642-1644, 2021 05 04.

Article en En | MEDLINE | ID: mdl-32628744

RESUMEN

Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.

Asunto(s)

Tratamiento Farmacológico de COVID-19; Adenosina Monofosfato/análogos & derivados; Alanina/análogos & derivados; Humanos; Unidades de Cuidados Intensivos; SARS-CoV-2; Sudáfrica/epidemiología

Palabras clave

COVID-19; SARS-CoV-2; hospital bed capacity; intensive care; mathematical model

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google